✦ LIBER ✦

OPL101 SENTINEL: a randomized controlled trial of natalizumab (tysabri®) and interferon beta-1a (AVONEX®) in relapsing multiple sclerosis (MS). Magnetic resonance imaging (MRI) results

Book ID: 119466455
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 130 KB
Volume: 238
Category: Article
ISSN: 0022-510X
DOI: 10.1016/s0022-510x(05)80277-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

OPL102 Subgroup analyses from SENTINEL:

OPL102 Subgroup analyses from SENTINEL: a randomized controlled trial of natalizumab (Tysabri®) and interferon beta-1a (AVONEX®) in relapsing multiple sclerosis (MS)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Magnetic resonance imaging results of th

Magnetic resonance imaging results of the PRISMS trial: A randomized, double-blind, placebo-controlled study of interferon-β1a in relapsing-remitting multiple sclerosis

✍ David K. B. Li; Donald W. Paty 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 2 views

The PRISMS (Prevention of Relapses and Disability by Interferon-␤1a Subcutaneously in Multiple Sclerosis) trial was a doubleblind, randomized, multicenter, phase III, placebo-controlled study of interferon-␤1a in 560 patients from 22 centers in 9 countries with clinically definite or laboratory-supp

Effect of interferon-β1b on magnetic res

Effect of interferon-β1b on magnetic resonance imaging outcomes in secondary progressive multiple sclerosis: Results of a European multicenter, randomized, double-blind, placebo-controlled trial

✍ D. H. Miller; P. D. Molyneux; G. J. Barker; D. G. MacManus; I. F. Moseley; K. Wa 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 1 views